NeoGenomics announces participation in key investor conferences in June
- NeoGenomics, a leading oncology testing services company, is set to hold presentations and discussions at two major investor conferences in June.
- The conferences will take place on June 3 and June 4, 2025, in Chicago and New York City respectively.
- The company's participation signals a commitment to transparency and engagement with its investors and stakeholders.
In an announcement dated May 20, 2025, NeoGenomics, Inc., a prominent player in the oncology testing services sector, revealed its lineup for upcoming investor conferences. The company's participation underscores its commitment to investor relations and transparency as it continues to expand its role in the oncology market. Two significant events are on the horizon for NeoGenomics: the William Blair 45th Annual Growth Stock Conference in Chicago, Illinois, where the company will present on June 3 at 1:00 PM Eastern Time, and the Jefferies Global Healthcare Conference in New York City, featuring a fireside chat on June 4 at 2:00 PM Eastern Time. This strategy highlights the growing interest surrounding oncology testing and diagnostic services, reflecting the industry's demand for innovative solutions that advance cancer care. Investors and stakeholders will have access to live and archived webcasts of these sessions via the Investor Relations section of NeoGenomics' website, facilitating engagement and discussion about the company's goals and advancements in oncology testing. Furthermore, NeoGenomics operates a network of laboratories that are both CAP-accredited and CLIA-certified, providing comprehensive testing services across the U.S. as well as a facility in Cambridge, United Kingdom. This global presence positions NeoGenomics favorably within a competitive market, aiming to serve oncologists, pathologists, and pharmaceutical companies with advanced diagnostic tools.